GlaxoSmithKline plc (GSK) Rating Reiterated by Liberum Capital

GlaxoSmithKline plc (GSK) Rating Reiterated by Liberum Capital


's stock had its "buy" rating reiterated by stock analysts at Liberum Capital in a report released on Thursday. They presently have a GBX 1,900 target price on the stock.



from Biotech News